Daria Eliseeva

Dr. Daria Eliseeva

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2016 in Autoimmunity
Verified
Journal Article
Closed access
GLGelena V. Lifshitz
Gelena V. Lifshitz
DZDmitry D. Zhdanov
Dmitry D. Zhdanov
ALAnastasia V. Lokhonina
Anastasia V. Lokhonina
DEDaria Eliseeva
Daria Eliseeva
ELElena Y. Lyssuck
Elena Y. Lyssuck
SBSvetlana N. Bykovskaia
Svetlana N. Bykovskaia
Multiple sclerosis (MS) is an autoimmune disease characterized by defect in regulatory function of CD4+CD25+ T cells. We demonstrated difference in proportion of regulatory T cells CD4+CD25+FoxP3+CD127low (Tregs) within the same patients’ relapse and remission. Proportion of peripheral Tregs (pTregs) dropped almost two times in the relapse compare to remission. Levels of pTregs in patients’ remission were lower than in healthy donors. Suppressive ability of pTregs was decreased in MS patients compared to healthy donors. Injections of expanded ex vivo autologous Tregs (eTregs) could be helpful in bringing up the level of Tregs in patients’ blood. We developed a simple method for ex vivo expansion of autologous Tregs within a short period of time. The final pool of cells consisted of 90-95% eTregs. When we started the culture with 10-20 × 106 CD4+ T cells, we yield 300-400 × 106 eTregs in a week. Expression of FoxP3 and Helios was calculated by two methods. Expanded ex vivo patients’ and donors’ Tregs were characterized by increased from three to five times expression of FoxP3, as well as almost doubled Helios expression. Peripheral Tregs in MS patients have decreased demethylation of FoxP3 gene promoter in comparison with donors. On the contrary, eTregs showed stable up-regulated demethylation without difference between MS patients and donors. MS patients’ and donors’ eTregs have much more suppressive ability than pTregs. Our data showed that eTregs can be applied as immunotherapy for MS patients and other autoimmune diseases if further investigated.

29 December 2023 in Cells
Verified
Journal Article
Open access
PDF file
VBVarvara Blinova
Varvara Blinova
YGYulia A. Gladilina
Yulia A. Gladilina
AAAnna A. Abramova
Anna A. Abramova
DEDaria Eliseeva
Daria Eliseeva
VVValentina V. Vtorushina
Valentina V. Vtorushina
DZDmitry D. Zhdanov
Dmitry D. Zhdanov
The maturation, development, and function of regulatory T cells (Tregs) are under the control of the crucial transcription factor Forkhead Box Protein 3 (FoxP3). Through alternative splicing, the human FoxP3 gene produces four different splice variants: a full-length variant (FL) and truncated variants with deletions of each of exons 2 (∆2 variant) or 7 (∆7 variant) or a deletion of both exons (∆2∆7 variant). Their involvement in the biology of Tregs as well as their association with autoimmune diseases remains to be clarified. The aim of this work was to induce a single FoxP3 splice variant in human Tregs by splice switching oligonucleotides and to monitor their phenotype and proliferative and suppressive activity. We demonstrated that Tregs from peripheral blood from patients with multiple sclerosis preferentially expressed truncated splice variants, while the FL variant was the major variant in healthy donors. Tregs with induced expression of truncated FoxP3 splice variants demonstrated lower suppressive activity than those expressing FL variants. Reduced suppression was associated with the decreased expression of Treg-associated suppressive surface molecules and the production of cytokines. The deletion of exons 2 and/or 7 also reduced the cell proliferation rate. The results of this study show an association between FoxP3 splice variants and Treg function and proliferation. The modulation of Treg suppressive activity by the induction of the FoxP3 FL variant can become a promising strategy for regenerative immunotherapy.

14 April 2023 in Biochemistry (Moscow)
Verified
Journal Article
Open access
PDF file
DEDaria Eliseeva
Daria Eliseeva
MZMaria N. Zakharova
Maria N. Zakharova
Demyelinating diseases of the central nervous system are caused by an autoimmune attack on the myelin sheath surrounding axons. Myelin structural proteins become antigenic, leading to the development of myelin lesions. The use of highly specialized laboratory diagnostic techniques for identification of specific antibodies directed against myelin components can significantly improve diagnostic approaches. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) currently includes demyelinating syndromes with known antigens. Based on the demonstrated pathogenic role of human IgG against MOG, MOGAD was classified as a distinct nosological entity. However, generation of multiple MOG isoforms by alternative splicing hinders antigen detection even with the most advanced immunofluorescence techniques. On the other hand, MOG conformational changes ensure the structural integrity of other myelin proteins and maintain human-specific mechanisms of immune autotolerance.

22 June 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
VBVarvara Blinova
Varvara Blinova
NNNatalia S. Novachly
Natalia S. Novachly
SGSofya N. Gippius
Sofya N. Gippius
AHAbdullah Hilal
Abdullah Hilal
YGYulia A. Gladilina
Yulia A. Gladilina
DZDmitry D. Zhdanov
Dmitry D. Zhdanov
Regulatory T cells (Tregs) participate in the negative regulation of inflammatory reactions by suppressing effector cells. In a number of autoimmune disorders, the suppressive function and/or the number of Tregs is compromised. The lack of active functioning Tregs can be restored with adoptive transfer of expanded ex vivo autologous Tregs. In our study, we traced the differentiation and maturation of Tregs CD4+CD25+FoxP3+CD127low over 7 days of cultivation from initial CD4+ T cells under ex vivo conditions. The resulting ex vivo expanded cell population (eTregs) demonstrated the immune profile of Tregs with an increased capacity to suppress the proliferation of target effector cells. The expression of the FoxP3 gene was upregulated within the time of expansion and was associated with gradual demethylation in the promotor region of the T cell-specific demethylation region. Real-time RT-PCR analysis revealed changes in the expression profile of genes involved in cell cycle regulation. In addition to FOXP3, the cells displayed elevated mRNA levels of Ikaros zinc finger transcription factors and the main telomerase catalytic subunit hTERT. Alternative splicing of FoxP3, hTERT and IKZF family members was demonstrated to be involved in eTreg maturation. Our data indicate that expanded ex vivo eTregs develop a Treg-specific phenotype and functional suppressive activity. We suggest that eTregs are not just expanded but transformed cells with enhanced capacities of immune suppression. Our findings may influence further development of cell immunosuppressive therapy based on regulatory T cells.

7 May 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
DZDmitry D. Zhdanov
Dmitry D. Zhdanov
YGYulia Gladilina
Yulia Gladilina
VBVarvara Blinova
Varvara Blinova
AAAnna A. Abramova
Anna A. Abramova
ASAnastasiya Shishparenok
Anastasiya Shishparenok
DEDaria Eliseeva
Daria Eliseeva
Forkhead box protein 3 (FoxP3) is a key transcription factor responsible for the development, maturation, and function of regulatory T cells (Tregs). The FoxP3 pre-mRNA is subject to alternative splicing, resulting in the translation of multiple splice variants. We have shown that Tregs from patients with amyotrophic lateral sclerosis (ALS) have reduced expression of full-length (FL) FoxP3, while other truncated splice variants are expressed predominantly. A correlation was observed between the reduced number of Tregs in the peripheral blood of ALS patients, reduced total FoxP3 mRNA, and reduced mRNA of its FL splice variant. Induction of FL FoxP3 was achieved using splice-switching oligonucleotides capable of base pairing with FoxP3 pre-mRNA and selectively modulating the inclusion of exons 2 and 7 in the mature mRNA. Selective expression of FL FoxP3 resulted in the induction of CD127low, CD152, and Helios-positive cells, while the cell markers CD4 and CD25 were not altered. Such Tregs had an increased proliferative activity and a higher frequency of cell divisions per day. The increased suppressive activity of Tregs with the induced FL FoxP3 splice variant was associated with the increased synthesis of the pro-apoptotic granzymes A and B, and perforin, IL-10, and IL-35, which are responsible for contact-independent suppression, and with the increased ability to suppress telomerase in target cells. The upregulation of Treg suppressive and proliferative activity using splice-switching oligonucleotides to induce the predominant expression of the FoxP3 FL variant is a promising approach for regenerative cell therapy in Treg-associated diseases.

1 January 2022 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
DEDaria Eliseeva
Daria Eliseeva
MZMariya N. Zakharova
Mariya N. Zakharova
Рассеянный склероз (РС) — хроническое воспалительное заболевание центральной нервной системы (ЦНС), которое приводит к формированию очагов первичной демиелинизации в белом и сером веществе и диффузному поражению аксонов и нейронов. Несмотря на значительный прогресс в разработке лекарственных средств для ремиттирующего РС, влияние на прогрессирование заболевания остается недостаточным. Диффузная и компартментализованная лимфоцитарная и макрофагальная инфильтрация ткани ЦНС ингибирует дифференцировку миелинизирующих зрелых олигодендроцитов и нарушает процессы ремиелинизации. Хроническое воспаление, которое возникает при сохранном гематоэнцефалическом барьере (ГЭБ), вызывает активацию микроглии, что усиливает повреждение аксонов и нейронов и, как следствие, запускает хронический оксидантный стресс и гистотоксическую гипоксию. В настоящее время является актуальным уточнение механизмов, лежащих в основе нейродегенерации, которая на поздних этапах РС обусловлена хроническим нейроаксональным поражением, нарушением регенеративных возможностей и в значительной степени определяет исход заболевания.